Drug Type Small molecule drug |
Synonyms CGS 18416, CGS 18416A, CGS-18416 + [1] |
Target |
Action antagonists |
Mechanism NMDA receptor antagonists(Glutamate [NMDA] receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC12H10ClN3O |
InChIKeyQMKRARTVXMQOBW-UHFFFAOYSA-N |
CAS Registry121929-20-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Epilepsy | Phase 1 | - | - |